
    
      This study will be a randomized, evaluator-blind, single-center, two-treatment regimen,
      controlled, parallel-group, with a treatment period of 4 weeks. The study will assess the
      skin barrier function of the two-treatment regimen in healthy participants with dry,
      sensitive skin on the face and lower legs. All participants will be centrally randomized to
      one of the 2 treatment groups using an Interactive Response Technology (IRT).
    
  